98%
921
2 minutes
20
This review systematically examined the reporting of sex and female participation in poststroke lower extremity motor rehabilitation randomized controlled trials over time and identified differences in female participation across randomized controlled trials conducted in low- and middle-income countries, high-income countries, and high-income country regions. Systematic searches were conducted of MEDLINE, Embase, CINAHL, and PsycINFO from 1970 to May 2022. Randomized controlled trials in English were included if they examined poststroke LE motor rehabilitation interventions in adults diagnosed with stroke. A total of 1283 randomized controlled trials were analyzed; 4.5% of randomized controlled trials did not report sex, and the overall female participation was 39.5%. The percentage of female participants did not significantly differ between high-income countries and low- and middle-income countries. Within high-income countries, the percentage of female participants was significantly higher in European randomized controlled trials than randomized controlled trials in Asia and Oceania ( P = 0.01). No significant changes in female participation were found for any of the countries or regions over the last two decades. Female participation was significantly higher in randomized controlled trials conducted in the acute phase compared to those in the chronic phase ( P < 0.001). More research is needed to understand the reasons behind female underenrollment and further efforts are required to ensure adequate enrollment of males and females.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/PHM.0000000000002638 | DOI Listing |
Scand J Rheumatol
September 2025
The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Frederiksberg, Denmark.
Objective: Pain hypersensitivity and hypersensitivity to other sensory modalities (visual, auditory, olfactory, and tactile) are considered defining features in nociplastic pain states. A self-report measure of sensory sensitivity may help to characterize sensory profiles across pain populations. This study aimed to evaluate the psychometric properties of a newly developed Danish nine-item Sensory Sensitivity Profile (SSP) questionnaire in patients with fibromyalgia.
View Article and Find Full Text PDFStroke
September 2025
Department of Medicine, University of Melbourne, Parkville, Victoria, Australia. (V.Y., B.C.V.C., L.C., L.O., M.W.P.).
Background: To assess the efficacy and safety of tenecteplase in patients presenting within 24 hours of symptom onset with a large vessel occlusion and target mismatch on perfusion computed tomography.
Methods: ETERNAL-LVO was a prospective, randomized, open-label, blinded end point, phase 3, superiority trial where adult participants with a large vessel occlusion, presenting within 24 hours of onset with salvageable tissue on computed tomography perfusion, were randomized to tenecteplase 0.25 mg/kg or standard care across 11 primary and comprehensive stroke centers in Australia.
Circulation
September 2025
Division of Cardiology, Columbia University Irving Medical Center, New York, NY (S.A.P.).
Background: Limited treatment options exist for infrapopliteal disease in patients with chronic limb-threatening ischemia (CLTI), a condition associated with a high risk of limb loss. Interventional management of diseased infrapopliteal vessels with percutaneous transluminal angioplasty (PTA) is associated with high rates of restenosis and reintervention. In the LIFE-BTK trial, the drug-eluting resorbable scaffold (DRS) demonstrated superior 12-month efficacy compared with PTA in a selected CLTI population with predominantly noncomplex, mildly to moderately calcified lesions.
View Article and Find Full Text PDFDan Med J
August 2025
Department of Clinical Medicine, Aarhus University.
Introduction: Reverse total shoulder arthroplasty is a well-established treatment for patients with rotator cuff tear arthropathy. The outcome after reverse total shoulder arthroplasty has been investigated in several studies and national registries. However, the treatment has not been compared to non-surgical treatment.
View Article and Find Full Text PDFEur J Case Rep Intern Med
July 2025
Servicio de Alergia e Inmunología, Hospital Británico de Buenos Aires, Argentina.
Introduction: Interstitial lung disease is a major complication in patients with common variable immunodeficiency. There are some publications that try to shed light on the pathophysiology of this non-infectious complication, most of them highlight the role of follicular T cells and CD21 B cells. Moreover, there are no guidelines based on randomized controlled studies on the treatment of patients with interstitial lung disease and the published case series or small uncontrolled studies describe a wide range of response rates to treatment.
View Article and Find Full Text PDF